40 cents per share post approval:
It could represent 20,000 USA patients that renew 50% of their scripts with BOT getting 200 profit per $750 unit sale.
Kaken just had 272,000 new patients last 12 months.
40 cents?
If the US gets 200,000 patients like the above more like $4.
3 times the population more like $12
More effective sales and marketting more like $$$$$$$$$$
40 cents is still massively priced in to be a flop.
- Forums
- ASX - By Stock
- Ann: Final Sofdra Labelling Discussions with FDA
40 cents per share post approval:It could represent 20,000 USA...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $784.5M |
Open | High | Low | Value | Volume |
43.0¢ | 44.5¢ | 42.0¢ | $1.545M | 3.579M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 503376 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 122413 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 423888 | 0.420 |
23 | 726345 | 0.415 |
20 | 894628 | 0.410 |
17 | 768929 | 0.405 |
28 | 742423 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 127747 | 11 |
0.430 | 865709 | 7 |
0.435 | 152255 | 6 |
0.440 | 845208 | 19 |
0.445 | 231011 | 11 |
Last trade - 13.21pm 13/09/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |